Literature DB >> 6712343

The evolution of reparative techniques for the mitral valve.

D L Nunley, A Starr.   

Abstract

Forty-eight adult patients underwent mitral valve repair for nonischemic valvular incompetence between 1963 and 1981. Early in our experience, 21 individuals received wedge leaflet resection or leaflet plication with posteromedial commissural annuloplasty. More recently, midleaflet annuloplasty has been employed in 13 patients and is now our preferred technique. Operative mortality was 6.3%, and all deaths occurred prior to 1973. Eventually valve replacement was necessary in 10 patients; all replacements were done prior to 1977. Technical errors and progression of rheumatic disease each accounted for half of these replacements. Five-year survival by the life table method was 74 +/- 9% for the entire group. Survival at 5 years for patients with prolapsing leaflets was significantly better (87 +/- 7%) than for those with normal leaflet motion (46 +/- 14%). A residual postoperative murmur of mitral insufficiency correlated with the likelihood of subsequent valve replacement. Important technical aspects of valve repair are described, and criteria for optimal patient selection are discussed. The evolution of reparative methods has led to a better understanding and broader application of mitral valve reconstruction.

Entities:  

Mesh:

Year:  1984        PMID: 6712343     DOI: 10.1016/s0003-4975(10)60762-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Intraoperative assessment of the reconstructed mitral valve: a simplified technique.

Authors:  P Fundaró; M Lemma; C Santoli
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Surgery for rheumatic mitral valve disease in sub-saharan African countries: why valve repair is still the best surgical option.

Authors:  Charles Mve Mvondo; Marta Pugliese; Alessandro Giamberti; David Chelo; Liliane Mfeukeu Kuate; Jerome Boombhi; Ellen Marie Dailor
Journal:  Pan Afr Med J       Date:  2016-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.